SCFA in gut health. Kristin Verbeke. On behalf of the Prebiotic Task Force of ILSI Europe

Size: px
Start display at page:

Download "SCFA in gut health. Kristin Verbeke. On behalf of the Prebiotic Task Force of ILSI Europe"

Transcription

1 SCFA in gut health Kristin Verbeke Translational Research in Gastrointestinal Disorders KU Leuven On behalf of the Prebiotic Task Force of ILSI Europe

2 Acetic acid Major anions in the large intestine Propionic acid Pass information from the diet and microbiota to the host inhibitors of HDAC ligands for GPR receptors Butyric acid

3 Gut health Bischoff S., BMC Medicine 2011; 9:24 3

4 Barrier function Epithelial cells Mucus Immune system antimicrobials Natividad et al. Pharmacological Research 2013; 69:

5 SCFA affect tight junctions Natividad et al. Pharmacological Research 2013; 69: Feldman et al. Advanced Drug Delivery Reviews 2005; 57:

6 SCFA affect tight junctions Peng et al. J Nutr 2009;139:

7 Butyrate stabilizes HIF-1 Kelly et al. Cell host & microbe 2015; 17:

8 SCFA stimulate proglucagon-derived peptide 2 (GLP-2) occludin ZO-1 jejunum colon antagonist agonist Cani et al. Gut 2009; 58:

9 Barrier function Epithelial cells Mucus Immune system antimicrobials Natividad et al. Pharmacological Research 2013; 69:

10 SCFA affect mucus production Stimulation of MUC2 gene expression Inhibition of histone deacetylation Synthesis of PGE1 Ex vivo stimulation of mucus production in human biopsies In vivo (humanised rats): increased mucin production In vivo (humans): no effect on MUC2 expression in HS (n=16) and UC patients (n=35) in remission after butyrate enemas (60 ml, 100 mm butyrate) for 2 wks Finnie et al. Gut. 1995;36(1):93-9. Van den Abbeele et al. Environm microbiol 2011 ;13: Hamer et al. Eur J Gastroenterol & hepatol 2010; 22:

11 SCFA affect mucus quality human intestinal epithelial goblet cells treated with 2 mm butyrate microarrays carrying cdna specific for 252 enzymes involved in glycosylation Confirmation with PCR upregulation of galectin-1 gene (LGALS1) expression Gaudier et al. Biochem biophys res comm 2004; 325:

12 Barrier function Epithelial cells Mucus Immune system antimicrobials Natividad et al. Pharmacological Research 2013; 69:

13 SCFA affect MAPK and NF-ĸB pathway Li et al. Eur J Pharmacol 2018; 831:

14 Involvement of the inflammasome pathway Macia et al. Nat Commun 2015; 6:

15 SCFA mediate colonic T reg Directly by interaction with T cells SCFA exposure ameliorates colitis in a T cell transfer model of colitis SCFA restore colonic T reg populations and function in germfree mice Smith et al. Science 2013;341: SCFA augment colonic T reg populations and function in SPFmice 15

16 SCFA mediate colonic T reg Via modulation of DC function DC exposed to butyrate increases the expression of IDO and Aldh 1A2 DC exposed to butyrate promote conversion to a tolerogenic phenotype in T-cells Gurav et al. Biochem J 2015; 469: DC exposed to butyrate suppress conversion into pro-inflammatory IFN-γ + T-cells 16

17 SCFA stimulate siga production Wildtype mice GPR43 -/- mice GPR43 -/- mice have lower faecal IgA and less IgA+ B-cells in their lamina propria Supplementation with acetate increased faecal IgA and IgA+ cells only in WT mice expression of Aldh1a2 was increased in acetate-treated DC acetate induction of RA expression enhances B cell IgA production RA treatment promoted B cell IgA production Wu et al. Mucosal immunology. 2017; 10:

18 Efficacy of SCFA in treatment of ulcerative colitis n Enema treatment Results Reference mm butyrate and placebo 100 ml, ph=7, b.d. for stool frequency, blood discharge, Scheppach wks. Wash out: 2wks endoscopic & histological scores 45 CS, 5 ASA or 130 mm SCFA (46:23:31*) 60 ml, ph=7, SCFAs equally efficacious to CS or 5 ASA Senagore 1992 b.d. for 6wks mm SCFA (53:20:27) vs. placebo 100 ml b.d. for SCFAs intestinal bleeding, urgency and Vernia wks patient self evaluation score mm SCFA (46:23:31) vs. 100 mm butyrate vs. No differences between groups. Scheppach 1996 Placebo 60 ml, ph=5.5, b.d. for 4 8 wks Butyrate for 8 wks fewer colonic segments affected endoscopically mm butyrate vs. placebo 60 ml, ph=7 for 6 wks No differences between butyrate and placebo Steinhart 1996 treatment mm SCFA (53:20:27) vs. placebo 100 ml, ph=7 no therapeutic value Breuer 1997 b.d. for 6 wks mm SCFA (46:23:31) vs. 100 mm butyrate vs. Placebo 60 ml, ph=5.5, b.d. for 4 8 wks Butyrate trend for reduced density of neutrophils in lamina propria. SCFA and butyrate cell proliferation in upper crypt Scheppach mm butyrate vs. placebo 60 ml, ph=5.5, b.d. for 4 8 wks Butyrate number of nuclear translocated NF κb positive macrophages, number of neutrophils and Disease Activity Index Luhrs ASA and saline vs. 5 ASA and 80 mm butyrate 80 ml b.d. for 6wks 5 ASA in combination with butyrate more patients into remission, bowel movements, urgency and patient s self evaluation Vernia 2003 Hamer et al. Aliment Pharmacol & Ther 2008; 27:

19 Barrier function Epithelial cells Mucus Immune system antimicrobials Natividad et al. Pharmacological Research 2013; 69:

20 Butyrate stimulates cathelicidin-ll37 HCA-7 cells HT-29 cells Hase et al. Infection and immunity 2002; 70: Schauber et al. Immunology 2006; 118:

21 Motility and transit: animal models Propionate and butyrate but not acetate induce contraction of colonic muscle ex vivo in rats Effects of SCFA are dose-dependent Effects of SCFA might differ between species Potential mechanisms: Secretion of PYY Interaction with GPR41 and GPR43 Stimulation of 5-HT release Saline 100 mm SCFA 500 mm SCFA Tazoe et al. J Physiol Pharmacol. 2008;59 Suppl 2: Mitsui et al. Neurogastroenterol Motil 2005; 17: Fukumoto et al. Am J Physiol Regul Integr Comp Physiol 2003; 284:R Cherbut et al. Am J Physiol 1998; 275: G

22 Motility and transit: humans Jouet et al. Neurogastroenterol Motil 2013; 25:

23 Calcium absorption: mechanisms luminal ph Ca-complexation Upregulation of proteins involved in paracellular Cauptake Transcription of TRP6 transcellular Ca-uptake Upregulation of calbindin-d9k Presence of Ca-H exchanger in distal colon Kashimura et al. Biol Trace Elem Res 1996; 54: Fukushima et al. J Nutr 2009; 139:20-5. Fukushima et al. J Nutr Sci Vitaminol 2012; 58: Lutz T, Scharrer E. Exp Physiol 1991; 76:

24 Calcium absorption Healthy subjects (n=6) Rectal infusions (300 ml) of 50 mm CaCl 2 56,3 mm acetate or 18.7 mm propionate or both Ca absorption linearly related to Ca concentration in the presence and absence of Ac and Pr, involves a non-saturable diffusion process Ca absorption is increased by Ac and Pr, and Ac and Pr absorption are stimulated by Ca. Trinidad et al. Nutrition Research. 1993;13: Trinidad et al. Am J Clin Nutr 1996;63: Trinidad et al. Adv Exp Med Biol 1997;427: Trinidad et al. Nutrition. 1999;15:

25 Calcium absorption p=0.04 Abrams et al. Am J Clin Nutr 2005; 82:

26 Conclusions In vitro and animal experiments provide compelling evidence for a role of SCFA in the improvement of gut barrier function although not completely resolved, molecular mechanisms have been studied extensively and in great detail In humans, it remains difficult to demonstrate improved barrier due to SCFA No studies directely assessed the impact of SCFA intervention on barrier function in humans Mixed results from studies that modulate the microbiota and presumably SCFA production Most studies did not measure SCFA or only measured faecal SCFA Assays that measure barrier function in vivo (most often permeability tests) suffer from considerable variability and might be not sensitive enough 26

27 Conclusions (II) At physiological concentrations, SCFA seem not to affect colonic motility in humans SCFA not only increase intestinal absorption of calcium but also result in higher bone mineral content and density. 27

28 28

Studies on probiotics effects on innate immune functions in the gastrointestinal tract of broiler chicks (SUMMARY)

Studies on probiotics effects on innate immune functions in the gastrointestinal tract of broiler chicks (SUMMARY) Doctoral Thesis Studies on probiotics effects on innate immune functions in the gastrointestinal tract of broiler chicks (SUMMARY) ELSAYED SEDDEK IBRAHEM MOHAMMED Department of Bioresource Science Graduate

More information

Diverticular Disease: Looking beyond fiber

Diverticular Disease: Looking beyond fiber Binghamton University The Open Repository @ Binghamton (The ORB) Health & Wellness Studies Faculty Scholarship Decker School of Nursing Fall 10-28-2015 Diverticular Disease: Looking beyond fiber Lina Begdache

More information

HOW THE MICROBIOME AFFECTS OUR HEALTH

HOW THE MICROBIOME AFFECTS OUR HEALTH HOW THE MICROBIOME AFFECTS OUR HEALTH THE INTESTINAL BARRIER AND INTESTINAL PERMEABILITY Intestinal Barrier: a functional body Defense from translocation of dietary antigens, bacteria or bacterial endotoxins

More information

Slide 1. Slide 2 Learning outcomes. Slide 3. Year 1 MBChB Lecture 15 Introduction to the Gut Microbiota. The importance of microbiota

Slide 1. Slide 2 Learning outcomes. Slide 3. Year 1 MBChB Lecture 15 Introduction to the Gut Microbiota. The importance of microbiota Slide 1 Year 1 MBChB Lecture 15 Introduction to the Gut Microbiota Professor Barry Campbell Gastroenterology Research Unit Cellular & Molecular Physiology, Institute of Translational Medicine bjcampbl@liv.ac.uk

More information

Necrotizing Enterocolitis: The Role of the Immune System

Necrotizing Enterocolitis: The Role of the Immune System Necrotizing Enterocolitis: The Role of the Immune System Patricia Denning, M.D. Associate Professor in Pediatrics Division of Neonatology Emory University School of Medicine What is NEC? What is NEC? Necrotizing

More information

Health Benefits of Prebiotic Dietary Fiber

Health Benefits of Prebiotic Dietary Fiber Health Benefits of Prebiotic Dietary Fiber JENNIFER ERICKSON, PhD, RD Objectives Provide some background on dietary fiber To define the term "prebiotic dietary fiber" To discuss potential health effects

More information

Towards Microbial Fermentation Metabolites as Biomarkers for Health Benefits of Prebiotics"

Towards Microbial Fermentation Metabolites as Biomarkers for Health Benefits of Prebiotics Towards Microbial Fermentation Metabolites as Biomarkers for Health Benefits of Prebiotics" Kieran Tuohy for working group on Microbial Metabolism and Fermentation SUPPORTED BY THE ILSI EUROPE PREBIOTICS

More information

Microbiome GI Disorders

Microbiome GI Disorders Microbiome GI Disorders Prof. Ram Dickman Neurogastroenterology Unit Rabin Medical Center Israel 1 Key Points Our gut microbiota Were to find them? Symbiosis or Why do we need them? Dysbiosis or when things

More information

Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells.

Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells. Chem Biol Interact. 2010 May 14;185(3):174-81. Epub 2010 Mar 25. Butyrate induces cell apoptosis through activation of JNK MAP kinase pathway in human colon cancer RKO cells. Zhang Y, Zhou L, Bao YL, Wu

More information

Faecalibacterium prausnitzii

Faecalibacterium prausnitzii Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients PNAS 105(43): 16731-16736, 2008. Speaker: Ming-Cheng Chen Advisor:

More information

Intestinal Microbiota in Health and Disease

Intestinal Microbiota in Health and Disease Intestinal Microbiota in Health and Disease February 27, 2015 Master s Course in Gastroenterology Prof. Kathy McCoy 1 Overview Overview of Gut Microbiota Microbiota in Health Microbiota in Disease 2 Gut

More information

Innate Immunity in the Intestine

Innate Immunity in the Intestine Master s course in biomedical sciences Innate Immunity in the Intestine Dr. Kathy McCoy February 26 th, 2013 1 Host-Microbial Homeostasis: Innate Immunity Pharynx & upper respiratory tract ~1010 - Barriers

More information

The Microbiome, Cancer and Cachexia

The Microbiome, Cancer and Cachexia Oslo, January 18, 2018 The Microbiome, Cancer and Cachexia Prof. Laure Bindels, PhD Dzutsev et al, Annu Rev Immunol 2017 Outline o Introduction to the gut microbiota o Gut microbiota-host crosstalk in

More information

What is the evidence that dietary components can act on the microbiome and influence health?

What is the evidence that dietary components can act on the microbiome and influence health? What is the evidence that dietary components can act on the microbiome and influence health? Kristin Verbeke Translational Research in Gastrointestinal Disorders KU Leuven, Leuven, Belgium Diet? health

More information

Genetics. Environment. You Are Only 10% Human. Pathogenesis of IBD. Advances in the Pathogenesis of IBD: Genetics Leads to Function IBD

Genetics. Environment. You Are Only 10% Human. Pathogenesis of IBD. Advances in the Pathogenesis of IBD: Genetics Leads to Function IBD Advances in the Pathogenesis of IBD: Genetics Leads to Function Pathogenesis of IBD Environmental Factors Microbes Scott Plevy, MD Associate Professor of Medicine, Microbiology & Immunology UNC School

More information

Probiotic bacteria: mechanisms of action?

Probiotic bacteria: mechanisms of action? Probiotic bacteria: mechanisms of action? Probiotic derived antibacterial substances (microcins) Competitive inhibition of pathogens Modulation of inflammatory responses: Increasing antiinflammatory cytokine

More information

Parenteral Nutrition. Outline. Potential Biomarkers for Use in Intestinal Adaptation. Jejunum is primary site of digestion and absorption

Parenteral Nutrition. Outline. Potential Biomarkers for Use in Intestinal Adaptation. Jejunum is primary site of digestion and absorption Outline Potential Biomarkers for Use in Intestinal Adaptation Kelly A. Tappenden, Ph.D., R.D. Professor of Nutrition and GI Physiology 1. Intestinal Adaptation potential regulators 2. Intestinal mucosal

More information

Bringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute

Bringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute Bringing Synbiotic Interventions in Cancer to Practice: from bench to bedside The UC Davis Foods for Health Institute Jennifer T. Smilowitz, PhD Associate Director, Human Studies Research jensm@ucdavis.edu

More information

Short Chain Fatty Acids and Poultry Gut Health Vanessa Iseri, PhD Kemin Industries, Inc.

Short Chain Fatty Acids and Poultry Gut Health Vanessa Iseri, PhD Kemin Industries, Inc. Short Chain Fatty Acids and Poultry Gut Health Vanessa Iseri, PhD Kemin Industries, Inc. Email: Vanessa.Iseri@kemin.com Introduction Due to customer demands, producers have been asked to change the way

More information

Faecal Calprotectin. Reliable Non-Invasive Discrimination Between Inflammatory Bowel Disease (IBD) & Irritable Bowel Syndrome (IBS)

Faecal Calprotectin. Reliable Non-Invasive Discrimination Between Inflammatory Bowel Disease (IBD) & Irritable Bowel Syndrome (IBS) Faecal Calprotectin Reliable Non-Invasive Discrimination Between Inflammatory Bowel Disease (IBD) & Irritable Bowel Syndrome (IBS) Reliable, Non Invasive Identification of IBD vs IBS Available from Eurofins

More information

ROLE OF THE GUT BACTERIA

ROLE OF THE GUT BACTERIA ROLE OF THE GUT BACTERIA Our Good Bacteria In a perfect world, we would all have a proper ratio of good bacteria And what could this proper ratio do for us? The knowledge of the connections between our

More information

Differential responses of human colonic ILCs to gut commensal bacteria altered during HIV infection

Differential responses of human colonic ILCs to gut commensal bacteria altered during HIV infection Differential responses of human colonic ILCs to gut commensal bacteria altered during HIV infection Moriah J. Castleman, Ph.D. Laboratory of Dr. Cara Wilson University of Colorado Anschutz Medical Campus

More information

Clinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut

Clinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut Clinically proven to quickly relieve symptoms of common gastrointestinal disorders GASTROINTESTINAL DISEASE Referred to as gastrointestinal diseases, they are common disorders which affect the esophagus,

More information

Grup de fisiologia digestiva i adaptacions nutricionals Institut de Nutrició i Seguretat Alimentaria

Grup de fisiologia digestiva i adaptacions nutricionals Institut de Nutrició i Seguretat Alimentaria Grup de fisiologia digestiva i adaptacions nutricionals Institut de Nutrició i Seguretat Alimentaria 1 Outline Weaning and the consequences of stress Animal blood plasma Spray-drying SDP SDP in a model

More information

Mucosal healing: does it really matter?

Mucosal healing: does it really matter? Oxford Inflammatory Bowel Disease MasterClass Mucosal healing: does it really matter? Professor Jean-Frédéric Colombel, New York, USA Oxford Inflammatory Bowel Disease MasterClass Mucosal healing: does

More information

Murine Models of. Inflammatory Bowel Disease. Outline. Laura P. Hale, M.D. Ph.D. Professor of Pathology Duke University Medical Center

Murine Models of. Inflammatory Bowel Disease. Outline. Laura P. Hale, M.D. Ph.D. Professor of Pathology Duke University Medical Center Murine Models of Inflammatory Bowel Disease Laura P. Hale, M.D. Ph.D. Professor of Pathology Duke University Medical Center September 19, 2017 Outline Review of IBD in humans Murine models of IBD Tissue

More information

Prevention and Therapy of Antibiotic Associated Diarrhea (ADD) through Probiotics

Prevention and Therapy of Antibiotic Associated Diarrhea (ADD) through Probiotics Prevention and Therapy of Antibiotic Associated Diarrhea (ADD) through Probiotics DGMIM, 15.-16.10.2010 16.10.2010 Stuttgart Prof. Rémy Meier, MD GI-Department University Hospital Liestal, Switzerland

More information

XV Jornada de Avances en Hepatología Málaga 20 y 21 de Mayo de Barrera intestinal en la cirrosis. Agustín Albillos

XV Jornada de Avances en Hepatología Málaga 20 y 21 de Mayo de Barrera intestinal en la cirrosis. Agustín Albillos XV Jornada de Avances en Hepatología Málaga 20 y 21 de Mayo de 2016 Barrera intestinal en la cirrosis Agustín Albillos Hospital Universitario Ramón y Cajal Universidad de Alcalá, Ciberehd Madrid, Spain

More information

Histological and immunological characteristics of colitis associated with anti-ctla 4 antibody therapy

Histological and immunological characteristics of colitis associated with anti-ctla 4 antibody therapy Histological and immunological characteristics of colitis associated with anti-ctla 4 antibody therapy M. Perdiki 2, G. Bamias 1, D. Pouloudi 2, H. Gogas 3, I. Delladetsima 2 1 Academic Dpt. of Gastroenterology,

More information

Dysbiosis & Inflammation

Dysbiosis & Inflammation MASTERING THE MICROBIOME: Dysbiosis & Inflammation 2017 Tom Fabian, PhD It is reasonable to propose that the composition of the microbiome and its activities are involved in most, if not all, of the biological

More information

Dietary Fiber and its Influence on Gut Health

Dietary Fiber and its Influence on Gut Health Dietary Fiber and its Influence on Gut Health Dietary Fiber and its Influence on Gut Health It is well known that dietary fiber plays a significant role in preventing non-communicable diseases such as

More information

ulcer healing role 118 Bicarbonate, prostaglandins in duodenal cytoprotection 235, 236

ulcer healing role 118 Bicarbonate, prostaglandins in duodenal cytoprotection 235, 236 Subject Index Actin cellular forms 48, 49 epidermal growth factor, cytoskeletal change induction in mucosal repair 22, 23 wound repair 64, 65 polyamine effects on cytoskeleton 49 51 S-Adenosylmethionine

More information

Diabetes and the Microbiome Structure, Function, and Terminology

Diabetes and the Microbiome Structure, Function, and Terminology Diabetes and the Microbiome Structure, Function, and Terminology Kim L. Kelly, PharmD, BCPS, FCCP, CDTC, CPC, CEC Kelly Diabetes Associates, LLC Cupertino, CA Patricia Davidson, DCN, RDN, CDE, LDN, FAND

More information

LECTURE 12: MUCOSAL IMMUNITY GUT STRUCTURE

LECTURE 12: MUCOSAL IMMUNITY GUT STRUCTURE LECTURE 12: MUCOSAL IMMUNITY GUT STRUCTURE - Small intestine in humans is around 3-4 metres long - Internal surface of the small intestines are lined by villi o Villi are composed of absorptive cells (epithelial/enterocytes)

More information

Reviewers' comments: Reviewer #1 (Remarks to the Author):

Reviewers' comments: Reviewer #1 (Remarks to the Author): Reviewers' comments: Reviewer #1 (Remarks to the Author): The manuscript by Sun et al., provide data showing that short-chain fatty acids produced by intestinal microbiota act through GPR43 to induced

More information

THE ROLE OF INTESTINAL EPITHELIAL CELLS AND THE REGULATION OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR IN HOMEOSTASIS AND INFLAMMATION

THE ROLE OF INTESTINAL EPITHELIAL CELLS AND THE REGULATION OF THE POLYMERIC IMMUNOGLOBULIN RECEPTOR IN HOMEOSTASIS AND INFLAMMATION University of Kentucky UKnowledge Theses and Dissertations--Microbiology, Immunology, and Molecular Genetics Microbiology, Immunology, and Molecular Genetics 2012 THE ROLE OF INTESTINAL EPITHELIAL CELLS

More information

The role of gut microbiome in IBS

The role of gut microbiome in IBS The role of gut microbiome in IBS Chung Owyang, MD H. Marvin Pollard Professor of Internal Medicine Professor of Molecular and Integrative Physiology Chief, Division of Gastroenterology Director, Pollard

More information

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI Gut Microbiota and IBD Vahedi. H M.D Associate Professor of Medicine DDRI 1393.3.1 2 GUT MICROBIOTA 100 Trillion Microbes - 10 times more than cells in our body Collective weight of about 1kg in human

More information

Unlocking the mysteries of gut comfort

Unlocking the mysteries of gut comfort Priority Research Programme Foods for improving gut function and comfort Unlocking the mysteries of gut comfort Nicole Roy, Professor AgResearch and Riddet Institute Host institution Foods for gut function

More information

Series Editors: Daniel Kamin, MD and Christine Waasdorp Hurtado, MD

Series Editors: Daniel Kamin, MD and Christine Waasdorp Hurtado, MD NASPGHAN Physiology Lecture Series GI Physiology Module: Absorption of Water and Ions Jason Soden, MD Reviewers: George Fuchs MD: UAMS College of Medicine / Arkansas Children s Hospital Wayne Lencer MD:

More information

D2 inhibits TLR2- initiated 12p40 transcription (-) TLR2 PGN MDP. MyD88 IRAK ECSIT TRAF6 NIK. Smallest unit of PGN muramyl dipeptide IKK.

D2 inhibits TLR2- initiated 12p40 transcription (-) TLR2 PGN MDP. MyD88 IRAK ECSIT TRAF6 NIK. Smallest unit of PGN muramyl dipeptide IKK. D2 inhibits TLR2- initiated 12p40 transcription CARD CARD NOD2 LRR RICK/Rip2 NIK MDP TRAF6 PGN TLR2 MyD88 IRAK ECSIT (-) IKK Smallest unit of PGN muramyl dipeptide IκB NF-κB atanabe et al, 2004 NF-κB IL-12p40

More information

17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012

17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012 17 th International Conference of the Inflammation Research Association: Wednesday AM (Day 4) September 9-13, 2012 The Sagamore Resort, Bolton Landing, NY, USA The following report includes highlights

More information

SUMMARY Coeliac disease is a common food intolerance in Western populations, in which it has a prevalence of about 1%. In early infancy, when the transition is made to a gluten-containing diet (particularly

More information

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine

Innate immune regulation of T-helper (Th) cell homeostasis in the intestine Innate immune regulation of T-helper (Th) cell homeostasis in the intestine Masayuki Fukata, MD, Ph.D. Research Scientist II Division of Gastroenterology, Department of Medicine, F. Widjaja Foundation,

More information

Ever wonder what s really happening on the inside?

Ever wonder what s really happening on the inside? For Practitioners Ever wonder what s really happening on the inside? Are your patients suffering from diarrhea, constipation, bloating, gas or indigestion? Rocky Mountain Analytical is now offering Gut-Well

More information

Asthma. In Europe ~30 million children and adults under 45 have asthma. On average 3 people a day die from asthma in the UK

Asthma. In Europe ~30 million children and adults under 45 have asthma. On average 3 people a day die from asthma in the UK Dr Neil Williams Nottingham Trent University College of Science and Technology Department of Sport Science Email: neil.williams@ntu.ac.uk @NeilW_ExPhys 1 Asthma In Europe ~30 million children and adults

More information

Short Bowel Syndrome: Medical management

Short Bowel Syndrome: Medical management Short Bowel Syndrome: Medical management La Sindrome dell'intestino Corto in età pediatrica Brescia 18 marzo 2011 Jon A.Vanderhoof, M.D. Division of Pediatric GI Harvard Medical School Children s Hospital,

More information

Exosomes as a. Novel Therapeutic Approach to Gastrointestinal Diseases Rebecca Murray APRN, FNP, CDE

Exosomes as a. Novel Therapeutic Approach to Gastrointestinal Diseases Rebecca Murray APRN, FNP, CDE Exosomes as a Novel Therapeutic Approach to Gastrointestinal Diseases Rebecca Murray APRN, FNP, CDE Endocrine Nurse Practitioner Institute for Hormonal Balance Orlando, FL Medical Director Ward-Murray

More information

Alexander Shikhman MD, PhD Institute for Specialized Medicine July 20, 2013

Alexander Shikhman MD, PhD Institute for Specialized Medicine July 20, 2013 Alexander Shikhman MD, PhD Institute for Specialized Medicine July 20, 2013 SPONDYLOARTHROPATHIES The spondyloarthropathy family consists of the following entities: Ankylosing spondylitis Undifferentiated

More information

BUTYRATE PRODUCING BACTERIA AS PROBIOTIC TREATMENT IN IBD

BUTYRATE PRODUCING BACTERIA AS PROBIOTIC TREATMENT IN IBD INTERNATIONAL SYMPOSIUM ON IBD RESEARCH FUNDED BY PATIENTS' ORGANISATIONS BUTYRATE PRODUCING BACTERIA AS PROBIOTIC TREATMENT IN IBD Annelies Geirnaert Laboratory of Microbial Ecology and Technology (LabMET),

More information

Fecal microbiota transplantation: The When,the How and the Don t. By Dr Rola Hussein

Fecal microbiota transplantation: The When,the How and the Don t. By Dr Rola Hussein Fecal microbiota transplantation: The When,the How and the Don t By Dr Rola Hussein Introduction Fecal microbiota transplantation (FMT) involves administration of fecal material containing distal gut microbiota

More information

A gut health approach to metabolic health.

A gut health approach to metabolic health. Medicine, Nursing and Health Sciences A gut health approach to metabolic health. Dr Jane Muir Head of Translational Nutrition Science Department of Gastroenterology, Central Clinical School RAPIDLY CONVERGING

More information

Intestinal Barrier Dysfunction: The Primary Driver of IBD?

Intestinal Barrier Dysfunction: The Primary Driver of IBD? 2 Intestinal Barrier Dysfunction: The Primary Driver of IBD? Pieter Hindryckx and Debby Laukens Ghent University Belgium 1. Introduction The healthy gastrointestinal tract is functionally maintained by

More information

Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis

Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis Research article Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis Weicheng Liu, 1 Yunzi Chen, 1,2 Maya Aharoni Golan, 1 Maria L. Annunziata, 1 Jie Du, 2 Urszula Dougherty,

More information

Signal Transduction in Inflammatory Bowel Disease

Signal Transduction in Inflammatory Bowel Disease E v e n t s 0 6 4 Signal Transduction in Inflammatory Bowel Disease 0 1 2 3 4 1 0 1 0 1 0 1 0 1 0 F L 2 - H e ig h t Vineeta Khare Ph.D Overview Inflammatory Bowel Diseases 1. Epidemiology, Symptoms and

More information

A Case of Inflammatory Bowel Disease

A Case of Inflammatory Bowel Disease A Case of Inflammatory Bowel Disease Dr Barrie Rathbone www.le.ac.uk 26 year old Polish woman Admitted as emergency under surgeons RUQ and RIF pain Abdominal pain had occurred intermittently for a few

More information

AVX-470, an Orally Delivered Anti-TNF Antibody for Treatment of Acute Ulcerative Colitis: Results of a First-in- Human Trial

AVX-470, an Orally Delivered Anti-TNF Antibody for Treatment of Acute Ulcerative Colitis: Results of a First-in- Human Trial AVX-470, an Orally Delivered Anti-TNF Antibody for Treatment of Acute Ulcerative Colitis: Results of a First-in- Human Trial M Scott Harris 1, Deborah Hartman 1, Sharon Spence 1, Sally Kennedy 1, Theodore

More information

Il microbiota intestinale: come regola la riserva e la spesa energetica? Gerardo Nardone.

Il microbiota intestinale: come regola la riserva e la spesa energetica? Gerardo Nardone. Il microbiota intestinale: come regola la riserva e la spesa energetica? Gerardo Nardone nardone@unina.it Department of Medicine and Surgery Gastroenterology Unit University Federico II, of Naples, Italy

More information

Efficacy and Safety of Treatment for Pediatric IBD

Efficacy and Safety of Treatment for Pediatric IBD Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Assistant Professor of Clinical Pediatrics Division of Gastroenterology,

More information

INTESTINAL DISEASE MEETING BERLIN Topical steroids rectal application

INTESTINAL DISEASE MEETING BERLIN Topical steroids rectal application INTESTINAL DISEASE MEETING BERLIN 2006 Topical steroids rectal application Prof. Dr. med. T. Andus Department of Internal Medicine, Gastroenterology, Hepatology, and Oncology Krankenhaus Bad Cannstatt,

More information

Exploring the link between gut microbiota and metabolic health

Exploring the link between gut microbiota and metabolic health Food Matters Live, Nov 21-23 rd, London Exploring the link between gut microbiota and metabolic health Ellen Blaak Professor in Physiology of fat metabolism, Department of Human Biology NUTRIM School of

More information

Mucosal Immunology Sophomore Dental and Optometry Microbiology Section I: Immunology. Robin Lorenz

Mucosal Immunology Sophomore Dental and Optometry Microbiology Section I: Immunology. Robin Lorenz Mucosal Immunology Sophomore Dental and Optometry Microbiology Section I: Immunology Robin Lorenz rlorenz@uab.edu Why do we Need to Understand How the Mucosal Immune System Works? The mucosa is the major

More information

Escherichia coli Nissle 1917

Escherichia coli Nissle 1917 Immunoregulation in Inflammatory Bowel Diseases New therapeutic approaches Probiotics Escherichia coli Nissle 1917 Andreas Sturm Medizinische Klinik m.s. Hepatologie, Gastroenterologie, Endokrinologie

More information

Efficacy and Safety of Treatment for Pediatric IBD

Efficacy and Safety of Treatment for Pediatric IBD Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Associate Professor of Clinical Pediatrics Division of Gastroenterology,

More information

Molecular and Cellular Basis of Immune Protection of Mucosal Surfaces

Molecular and Cellular Basis of Immune Protection of Mucosal Surfaces Molecular and Cellular Basis of Immune Protection of Mucosal Surfaces Department of Biologic & Materials Sciences School of Dentistry University of Michigan Ann Arbor, Michigan 48109-1078 1 Image quality

More information

Once Daily Dosing for Induction and Maintenance of Remission in Ulcerative Colitis

Once Daily Dosing for Induction and Maintenance of Remission in Ulcerative Colitis Once Daily Dosing for Induction and Maintenance of Remission in Ulcerative Colitis John K. Marshall MD MSc FRCPC AGAF Division of Gastroenterology McMaster University JKM 2014 Svartz N. Acta Med Scand

More information

A Conceptual Framework for Defining Mechanisms of Probiotic Action

A Conceptual Framework for Defining Mechanisms of Probiotic Action A Conceptual Framework for Defining Mechanisms of Probiotic Action Prof. Sarah Lebeer UAntwerpen (BE) ILSI Session - How Do Prebiotics and Probiotics Work? Mechanistic Insights Into Their Function Probiotics

More information

FERRING PHARMACEUTICALS. Enjoy The simple COR/939/2014/CH3

FERRING PHARMACEUTICALS. Enjoy The simple COR/939/2014/CH3 Enjoy The simple pleasures of life COR/939/2014/CH3 Ulcerative colitis disrupts the simple pleasures in life Patients with ulcerative colitis may live with a considerable symptom burden despite medical

More information

Modulation of abdominal pain by probiotics. Anna Lyra, PhD DuPont Nutrition & Health

Modulation of abdominal pain by probiotics. Anna Lyra, PhD DuPont Nutrition & Health Modulation of abdominal pain by probiotics Anna Lyra, PhD DuPont Nutrition & Health Functional gastrointestinal (GI) wellbeing Up to 70% suffer from functional GI symptoms - ¾ do not seek medical care

More information

SAM PROVIDER TOOLKIT

SAM PROVIDER TOOLKIT THE AMERICAN BOARD OF PATHOLOGY Maintenance of Certification (MOC) Program SAM PROVIDER TOOLKIT Developing Self-Assessment Modules (SAMs) www.abpath.org The American Board of Pathology (ABP) approves educational

More information

Outline. Epidemiology of Pediatric HIV 10/3/2012. I have no financial relationships with any commercial entity to disclose

Outline. Epidemiology of Pediatric HIV 10/3/2012. I have no financial relationships with any commercial entity to disclose Nutritional, Metabolic, and Gastrointestinal Complications in Pediatric HIV Infection Tracie L. Miller, MD Department of Pediatrics University of Miami, Miller School of Medicine I have no financial relationships

More information

Positioning Biologics in Ulcerative Colitis

Positioning Biologics in Ulcerative Colitis Positioning Biologics in Ulcerative Colitis Bruce E. Sands, MD, MS Acting Chief, Gastrointestinal Unit Massachusetts General Hospital Associate Professor of Medicine Harvard Medical School Sequential Therapies

More information

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology Patho Basic Chronic Inflammatory Bowel Diseases Jürg Vosbeck Pathology General Group of chronic relapsing diseases with chronic bloody or watery diarrhea Usually ulcerative colitis (UC) or Crohn s disease

More information

Mild-moderate Ulcerative Colitis Sequential & Combined treatments need to be tested. Philippe Marteau, Paris, France

Mild-moderate Ulcerative Colitis Sequential & Combined treatments need to be tested. Philippe Marteau, Paris, France Mild-moderate Ulcerative Colitis Sequential & Combined treatments need to be tested Philippe Marteau, Paris, France Sequential vs combined treatments When should one switch? Sequential vs combined treatments

More information

Cannabis finds its way into treatment of Crohn s disease

Cannabis finds its way into treatment of Crohn s disease Europe PMC Funders Group Author Manuscript Published in final edited form as: Pharmacology. 2014 ; 93(0): 1 3. doi:10.1159/000356512. Cannabis finds its way into treatment of Crohn s disease Rudolf Schicho

More information

Aminosalicylates. Giovanni Barbara. Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Italy ( )

Aminosalicylates. Giovanni Barbara. Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Italy ( ) Aminosalicylates Giovanni Barbara Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Italy (1088 2016) Colonic Diverticula, a Painless Ageing Change? 20% develop symptoms

More information

What Have We Learned About the Microbiome in Pediatric IBD?

What Have We Learned About the Microbiome in Pediatric IBD? What Have We Learned About the Microbiome in Pediatric IBD? Ted Denson, MD Cincinnati Children s Hospital Medical Center and the University of Cincinnati College of Medicine Disclosures: NIH, CCF, AbbVie

More information

The two different types of fibers are soluble and insoluble fibers

The two different types of fibers are soluble and insoluble fibers FIBER FACTS Fiber is the indigestible remnants of plant cells found in fruits, vegetables, whole grains, nuts, seeds, and beans, act through the digestive tract. It cannot be digested by enzymes present

More information

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic INFLAMMATORY BOWEL DISEASE Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic WHAT IS INFLAMMATORY BOWEL DISEASE (IBD)? Chronic inflammation of the intestinal tract Two related

More information

Mucosal immunity Reddy April Deveshni Reddy Allergy Meeting 13 April 2012

Mucosal immunity Reddy April Deveshni Reddy Allergy Meeting 13 April 2012 Deveshni Reddy Allergy Meeting 13 April First recorded by Hippocrates over 2000 years ago. 1921: Prausnitz and Kustner demonstrated that substance responsible for Kustner s fish allergy was present in

More information

Unlocking the mysteries of gut comfort

Unlocking the mysteries of gut comfort Priority Research Programme Foods for improving gut function and comfort Unlocking the mysteries of gut comfort Nicole Roy, Professor AgResearch and Riddet Institute Host institution Foods for gut function

More information

CROHN S DISEASE AND ULCERATIVE COLITIS

CROHN S DISEASE AND ULCERATIVE COLITIS Slide 1 CROHN S DISEASE AND ULCERATIVE COLITIS Slide 2 Slide 3 Crohn s Inflammation in the GI tract but usually in the lower part of the small intestines and the colon. Inflammation occur between healthy

More information

Exploration of the microbiota in inflammatory diseases. Matthew Stoll MD Research Computing Day September 13, 2012

Exploration of the microbiota in inflammatory diseases. Matthew Stoll MD Research Computing Day September 13, 2012 Exploration of the microbiota in inflammatory diseases Matthew Stoll MD Research Computing Day September 13, 2012 We re surrounded by bugs Human body contains 100 trillion microbes Out-number human cells

More information

What do we need for diagnosis of IBD

What do we need for diagnosis of IBD What do we need for diagnosis of IBD Kaichun Wu Dept. of Gastroenterology, Xijing Hospital Fourth Military Medical University Xi an an,, China In China UC 11.6/10 5,CD 1.4/10 5 Major cause of chronic diarrhea

More information

12/10/2009. Department of Pathology, Case Western Reserve University. Mucosal Cytokine Network in IBD

12/10/2009. Department of Pathology, Case Western Reserve University. Mucosal Cytokine Network in IBD Cytokine-Mediated Inflammation in IBD Theresa T. Pizarro Department of Pathology, Case Western Reserve University Mucosal Cytokine Network in IBD Andoh, et al., 2008 1 Interleukin-1 (IL-1) Family Cytokine

More information

ESPEN Congress Vienna Networking with your microbiota Specific evidence-based indications. H. Lochs (Germany)

ESPEN Congress Vienna Networking with your microbiota Specific evidence-based indications. H. Lochs (Germany) ESPEN Congress Vienna 2009 Networking with your microbiota Specific evidence-based indications H. Lochs (Germany) Probiotics Evidence based indications H. Lochs Medizinische Klinik mit Schwerpunkt Gastroenterologie,

More information

Accepted Manuscript. Innate immune cells regulate oncoimmunity and cancer development. Ai-Ping Bai, Yuan Guo

Accepted Manuscript. Innate immune cells regulate oncoimmunity and cancer development. Ai-Ping Bai, Yuan Guo Accepted Manuscript Innate immune cells regulate oncoimmunity and cancer development Ai-Ping Bai, Yuan Guo PII: S0016-5085(18)34974-6 DOI: 10.1053/j.gastro.2018.08.057 Reference: YGAST 62119 To appear

More information

Ali Keshavarzian MD Rush University Medical Center, Chicago, IL

Ali Keshavarzian MD Rush University Medical Center, Chicago, IL Ali Keshavarzian MD Rush University Medical Center, Chicago, IL Ulcerative colitis Crohn s disease Optimize Quality of Life Induce remission [treat flare up] Maintain remission [avoid flare up] Prevent

More information

INTRODUCING YOUR GUT BACTERIA

INTRODUCING YOUR GUT BACTERIA INTRODUCING YOUR GUT BACTERIA Microflora Intestinal flora 1.5 kg We would die with 5 years of birth if we did not have them as we would not develop a proper immune system 1000 species and 5000 strains

More information

Research Update: Looking for the Answers

Research Update: Looking for the Answers Research Update: Looking for the Answers Ted Denson, M.D. Schubert-Martin Inflammatory Bowel Disease Center Research Support: NIH/NIDDK, CCFA, BMRP Figure 2 Approach to Improve Outcomes for our IBD Patients

More information

Putting it Together. Stephen Canfield Secondary Lymphoid System. Tonsil Anterior Cervical LN s

Putting it Together. Stephen Canfield Secondary Lymphoid System. Tonsil Anterior Cervical LN s Putting it Together Stephen Canfield smc12@columbia.edu Secondary Lymphoid System Tonsil Anterior Cervical LN s Axillary LN s Mediastinal/Retroperitoneal LN s Thoracic Duct Appendix Spleen Inguinal LN

More information

The Role of MicroRNAs in NEC Misty Good, MD

The Role of MicroRNAs in NEC Misty Good, MD The Role of MicroRNAs in NEC Misty Good, MD Neonatologist, Assistant Professor of Pediatrics Division of Newborn Medicine, Children s Hospital of Pittsburgh Department of Pediatrics, University of Pittsburgh

More information

Review article: induction therapy for patients with active ulcerative colitis

Review article: induction therapy for patients with active ulcerative colitis Alimentary Pharmacology & Therapeutics Review article: induction therapy for patients with active ulcerative colitis S. P. L. TRAVIS John Radcliffe Hospital and Linacre College, Oxford, UK Correspondence

More information

Welke rol speelt het microbioom bij malaborptie? - Microbiome and malabsorption -

Welke rol speelt het microbioom bij malaborptie? - Microbiome and malabsorption - Welke rol speelt het microbioom bij malaborptie? - Microbiome and malabsorption - Daisy Jonkers Division Gastroenterology-Hepatology Maastricht University Medical Center+ 20 april 2017 d.jonkers@maastrichtuniversity.nl

More information

DESIGN AND DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM OF 5 FLUORURACIL & METRONIDAZOLE

DESIGN AND DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM OF 5 FLUORURACIL & METRONIDAZOLE 1. Introduction: DESIGN AND DEVELOPMENT OF COLON TARGETED DRUG DELIVERY SYSTEM OF 5 FLUORURACIL & METRONIDAZOLE Oral controlled - release formulations for the small intestine and colon have received considerable

More information

1. Digestion of foods and absorption of nutrients takes place in stomach and small bowel in only 2-3 h.

1. Digestion of foods and absorption of nutrients takes place in stomach and small bowel in only 2-3 h. 1. Digestion of foods and absorption of nutrients takes place in stomach and small bowel in only 2-3 h. 2. The waste is then stored for 2 days in the large bowel. 3. Do modern humans need a large bowel?

More information

Mucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium

Mucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium Mucosal Healing in Crohn s Disease Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium Mucosal Lesions in CD: General Features CD can affect the entire GI tract

More information

SER-287 Phase 1b topline study results in patients with mild-to-moderate Ulcerative Colitis October 2, 2017

SER-287 Phase 1b topline study results in patients with mild-to-moderate Ulcerative Colitis October 2, 2017 SER-287 Phase 1b topline study results in patients with mild-to-moderate Ulcerative Colitis October 2, 2017 Leading the Microbiome Revolution Forward Looking Statements Some of the statements in this presentation

More information

Recent Advances in the Management of Refractory IBD

Recent Advances in the Management of Refractory IBD Recent Advances in the Management of Refractory IBD Raina Shivashankar, M.D. Assistant Professor of Medicine Division of Gastroenterology and Hepatology Thomas Jefferson University Philadelphia, PA Outline

More information

Fructo-oligosaccharides in Crohn s disease: a prospective randomised double blind controlled trial

Fructo-oligosaccharides in Crohn s disease: a prospective randomised double blind controlled trial Fructo-oligosaccharides in Crohn s disease: a prospective randomised double blind controlled trial Principal investigator: Dr James Lindsay St Bartholomew's Hospital and The Royal London Hospital Queen

More information